Lab901 today announced that it has been awarded ISO 9001:2008 accreditation for manufacturing quality covering its ScreenTape^® System for automated gel electrophoresis. ISO 9001:2008 addresses quality management systems and looks at, among other things, what an organisation does to fulfil a customer's quality requirements and enhance customer satisfaction. The new accreditation underlines Lab901's commitment to a quality system approach which ultimately benefits its customer base across the biotech and pharmaceutical industries, as well as research and academia. 

With expertise in automated biomolecular detection and analysis, Lab901 is the originator of the ScreenTape System, the first fully automated solution for gel electrophoresis.  The ScreenTape system delivers analysed results in around 1 minute per sample, and is increasingly used for applications in research and diagnostic laboratories around the world, which require rapid and convenient RNA, DNA and protein analysis. 

The widespread adoption of ISO Standards enables businesses to develop and offer products and services meeting specifications that have wide international acceptance in their sectors. Commenting on the accreditation, Joel Fearnley, CEO and co-founder of Lab901, said: "We are really pleased to have been awarded ISO 9001.  We pride ourselves on developing and manufacturing our products to the highest of quality standards and this is a great reflection on the dedication of the Lab901 team." 

For more information on Lab901 and the range of ScreenTape products for automated RNA QC, SDS-PAGE and multiplex PCR diagnostics, please visit www.lab901.com